Live Breaking News & Updates on Petrichor Healthcare Capital

Stay updated with breaking news from Petrichor healthcare capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA finally signs off on Fennec Pharma drug for chemo-caused hearing loss in kids

A Fennec Pharmaceuticals drug that prevents hearing loss in children receiving cancer treatment is now approved. The regulatory decision comes more than two years later than expected, but the company now claims its drug, Pedmark, is the first and only FDA-approved therapy for reducing the risk of chemotherapy-induced hearing loss in pediatric cancer patients. ....

United States , Fennec Pharmaceuticals , Oregon Health Science University , Research Triangle Park , Triangle Park , North Carolina Based Fennec , Oregon Health , Late August , Petrichor Healthcare Capital , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery ,

Fennec Pharmaceuticals Closes First $5 Million Investment From Petrichor

22.08.2022 - ~ Under the Terms of the Investment Agreement, $5 Million to be Funded on initial closing and $20 Million to be Funded Upon Potential FDA Approval of PEDMARKTM ~ ~ Fennec Has the Potential to Access an Additional $20 Million Prior to December 31, . Seite 1 ....

Exchange Commission , Fennec Pharmaceuticals Inc , Drug Administration , Company Manual , Petrichor Healthcare Capital , Current Report , Securities Act ,